Anzeige
Mehr »
Login
Donnerstag, 02.05.2024 Börsentäglich über 12.000 News von 685 internationalen Medien
"Special Situation"-Aktie mit Multi-Tenbagger-Potenzial im heißesten Rohstoff-Markt
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
113 Leser
Artikel bewerten:
(0)

IPC The Hospitalist Company Acquires Two New England Practices

NORTH HOLLYWOOD, Calif., Nov. 18 /PRNewswire-FirstCall/ -- IPC The Hospitalist Company announced today that it has acquired Hospital Internists of New London (HINL), based in New London, Connecticut, and Hospital Internists of Westerly (HIW), based in Westerly, Rhode Island. The acquisition of these two practices marks IPC's expansion into two additional states, raising the company's presence to 21 states. The two practices combined have approximately 55,000 patient encounters annually.

Adam Singer, M.D., chairman and CEO of IPC, said, "The acquisition of these practices continues our expansion into New England and the northeast corridor. These two groups have done an excellent job of partnering with their hospitals to deliver high quality care and meet other important hospital goals. We look forward to maintaining and enhancing these partnerships by providing the existing hospitalist teams the tools and resources they need to continuously improve service levels."

Kevin Shushtari M.D., founder of both practices and one of the pioneers of the hospital medicine specialty, commented, "It is gratifying to have these practices become part of the leading hospitalist company in the country. The financial, management and technology resources that IPC offers will enable both of these practice groups to achieve new milestones in delivering high quality and cost-effective inpatient care."

Ken Donovan MD, Medical Director of HINL, added, "Going forward, local hospitalist practices will better serve their patients and help themselves by partnering with a sophisticated organization like IPC. Trying to build or buy all the infrastructure that IPC offers is too complicated, expensive, and risky for a small group. By partnering with IPC, our practice groups have access to world-class resources, while maintaining the autonomy that is important to our physicians."

About IPC The Hospitalist Company, Inc.

IPC The Hospitalist Company, Inc. is a leading physician group practice company focused on the delivery of hospitalist medicine services. IPC's physicians and affiliated providers manage the care of hospitalized patients in coordination with primary care physicians and specialists. The Company provides its hospitalists with the comprehensive training, information technology, and management support systems necessary to improve the quality and reduce the cost of inpatient care in the facilities it serves. For more information, visit the IPC website at http://www.hospitalist.com/.

Media Contact: Elaine Murphy Scott Public Relations 818.610.0270 elaine@scottpublicrelations.com Investor Contacts: The Ruth Group Amy Glynn/Nick Laudico 646.536.7023/7030 aglynn@theruthgroup.com nlaudico@theruthgroup.com

IPC The Hospitalist Company, Inc.

CONTACT: Media: Elaine Murphy, Scott Public Relations, +1-818-610-0270,
elaine@scottpublicrelations.com; or Investor: The Ruth Group, Amy Glynn,
+1-646-536-7023, aglynn@theruthgroup.com, or Nick Laudico, +1-646-536-7030,
nlaudico@theruthgroup.com

Web Site: http://www.hospitalist.com/

Lithium vs. Palladium - Zwei Rohstoff-Chancen traden
In diesem kostenfreien PDF-Report zeigt Experte Carsten Stork interessante Hintergründe zu den beiden Rohstoffen inkl. . Zudem gibt er Ihnen konkrete Produkte zum Nachhandeln an die Hand, inkl. WKNs.
Hier klicken
© 2009 PR Newswire
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.